Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local dexamethasone for pain and swelling after impacted third molar surgery
IRCT20220117053746N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in impacted third molar (I3M), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Postoperative pain and Postoperative swelling. Started Feb 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on IRCT20220117053746N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220117053746N1.